Amgen Down Over 13%, Worst Performer in the DJIA and Nasdaq 100 So Far Today — Data Talk
Amgen Inc. (AMGN) is currently at $298.03, down $13.26 or 4.26%
--On pace for largest percent decrease since Feb. 7, 2024, when it fell 6.39%
--Snaps a three day winning streak
--Up 3.48% year-to-date
--Down 8.17% from its all-time closing high of $324.56 on Feb. 1, 2024
--Up 27.03% from 52 weeks ago (May 8, 2023), when it closed at $234.62
--Down 8.17% from its 52-week closing high of $324.56 on Feb. 1, 2024
--Up 39.09% from its 52-week closing low of $214.27 on June 1, 2023
--Traded as low as $297.52
--Down 4.42% at today's intraday low; largest intraday percent decrease since Feb. 7, 2024, when it fell as much as 6.58%
--Worst performer in the DJIA today
--Second worst performer in the S&P 500 today
--Worst performer in the Nasdaq 100 today
--Subtracted 87.11 points from the DJIA so far today
All data as of 12:01:03 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2024 12:20 ET (16:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations